Inhaled medication therapy for bronchiectasis: status quo and the next frontier

Expert Opin Investig Drugs. 2018 Mar;27(3):211-218. doi: 10.1080/13543784.2018.1439919. Epub 2018 Feb 15.

Authors

Chun-Lan Chen¹, Yan Huang¹, Yong-Hua Gao², Rong-Chang Chen¹, Nan-Shan Zhong¹, Wei-Jie Guan^{1

3}

Affiliations

¹ a State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University , Guangzhou , Guangdong , China.
² b First Affiliated Hospital of Zhengzhou University , Zhengzhou , China.
³ c Sino-French Hoffmann Institute, Guangzhou Medical University , Guangzhou , China.

PMID: 29425474
DOI: 10.1080/13543784.2018.1439919

No abstract available

Keywords: Bronchiectasis; antibiotics; exacerbation; inhaled medication; pseudomonas aeruginosa.

Publication types

Editorial

MeSH terms

Administration, Inhalation
Anti-Bacterial Agents / administration & dosage*
Bronchiectasis / drug therapy*
Humans
Pharmaceutical Preparations / administration & dosage*

Substances

Anti-Bacterial Agents
Pharmaceutical Preparations